Abbott Laboratories operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Abbott Laboratories with three other companies in this sector in the United States: Abbvie Inc (2018 sales of $32.75 billion of which 100% was Pharmaceutical Products), Bristol-Myers Squibb Company ($22.56 billion of which 100% was BioPharmaceuticals), and Eli Lilly and Company ($24.56 billion of which 48% was Human pharmaceutical products - Endocrin).

Sales Analysis. During the year ended December of 2018, sales at Abbott Laboratories were $30.58 billion. This is an increase of 11.6% versus 2017, when the company's sales were $27.39 billion. This was the fourth straight year of sales growth at Abbott Laboratories. Sales of Diagnostics Products saw an increase that was more than double the company's growth rate: sales were up 33.5% in 2018, from $5.62 billion to $7.50 billion. Abbott Laboratories also saw significant increases in sales in Other (up 20.8% to $2.00 billion) .